Logo image of CTS

CTS CORP (CTS) Stock Fundamental Analysis

NYSE:CTS - New York Stock Exchange, Inc. - US1265011056 - Common Stock

52.84  +1.2 (+2.32%)

After market: 52.84 0 (0%)

Fundamental Rating

6

Overall CTS gets a fundamental rating of 6 out of 10. We evaluated CTS against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CTS gets an excellent profitability rating and is at the same time showing great financial health properties. CTS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CTS was profitable.
CTS had a positive operating cash flow in the past year.
CTS had positive earnings in 4 of the past 5 years.
In the past 5 years CTS always reported a positive cash flow from operatings.
CTS Yearly Net Income VS EBIT VS OCF VS FCFCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.58%, CTS belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
With a decent Return On Equity value of 11.27%, CTS is doing good in the industry, outperforming 77.50% of the companies in the same industry.
The Return On Invested Capital of CTS (8.57%) is better than 76.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTS is in line with the industry average of 9.03%.
Industry RankSector Rank
ROA 7.58%
ROE 11.27%
ROIC 8.57%
ROA(3y)3.28%
ROA(5y)4.2%
ROE(3y)4.74%
ROE(5y)6.27%
ROIC(3y)10.77%
ROIC(5y)9.58%
CTS Yearly ROA, ROE, ROICCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin of CTS (11.66%) is better than 85.83% of its industry peers.
In the last couple of years the Profit Margin of CTS has grown nicely.
Looking at the Operating Margin, with a value of 14.84%, CTS belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
In the last couple of years the Operating Margin of CTS has remained more or less at the same level.
CTS's Gross Margin of 36.00% is fine compared to the rest of the industry. CTS outperforms 60.83% of its industry peers.
In the last couple of years the Gross Margin of CTS has remained more or less at the same level.
Industry RankSector Rank
OM 14.84%
PM (TTM) 11.66%
GM 36%
OM growth 3Y10.5%
OM growth 5Y1.24%
PM growth 3Y10.36%
PM growth 5Y2.16%
GM growth 3Y1.87%
GM growth 5Y-0.23%
CTS Yearly Profit, Operating, Gross MarginsCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTS is creating some value.
Compared to 1 year ago, CTS has less shares outstanding
CTS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CTS has been reduced compared to a year ago.
CTS Yearly Shares OutstandingCTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CTS Yearly Total Debt VS Total AssetsCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.03 indicates that CTS is not in any danger for bankruptcy at the moment.
CTS has a Altman-Z score of 6.03. This is in the better half of the industry: CTS outperforms 79.17% of its industry peers.
The Debt to FCF ratio of CTS is 1.15, which is an excellent value as it means it would take CTS, only 1.15 years of fcf income to pay off all of its debts.
CTS's Debt to FCF ratio of 1.15 is fine compared to the rest of the industry. CTS outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that CTS is not too dependend on debt financing.
CTS has a Debt to Equity ratio (0.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.15
Altman-Z 6.03
ROIC/WACC0.82
WACC10.42%
CTS Yearly LT Debt VS Equity VS FCFCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.3 Liquidity

CTS has a Current Ratio of 2.46. This indicates that CTS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.46, CTS is in line with its industry, outperforming 54.17% of the companies in the same industry.
A Quick Ratio of 1.91 indicates that CTS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.91, CTS is in line with its industry, outperforming 57.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.91
CTS Yearly Current Assets VS Current LiabilitesCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

CTS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.26%.
Measured over the past 5 years, CTS shows a small growth in Earnings Per Share. The EPS has been growing by 7.63% on average per year.
The Revenue has decreased by -9.68% in the past year.
Measured over the past years, CTS shows a small growth in Revenue. The Revenue has been growing by 3.19% on average per year.
EPS 1Y (TTM)-8.26%
EPS 3Y25.43%
EPS 5Y7.63%
EPS Q2Q%16.67%
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y9.08%
Revenue growth 5Y3.19%
Sales Q2Q%-1.58%

3.2 Future

The Earnings Per Share is expected to grow by 7.26% on average over the next years.
Based on estimates for the next years, CTS will show a small growth in Revenue. The Revenue will grow by 2.05% on average per year.
EPS Next Y-0.37%
EPS Next 2Y4.07%
EPS Next 3Y7.26%
EPS Next 5YN/A
Revenue Next Year-5.29%
Revenue Next 2Y0.12%
Revenue Next 3Y2.05%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTS Yearly Revenue VS EstimatesCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
CTS Yearly EPS VS EstimatesCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.04, which means the current valuation is very expensive for CTS.
70.00% of the companies in the same industry are more expensive than CTS, based on the Price/Earnings ratio.
CTS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 22.07 indicates a rather expensive valuation of CTS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTS indicates a somewhat cheap valuation: CTS is cheaper than 68.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, CTS is valued at the same level.
Industry RankSector Rank
PE 25.04
Fwd PE 22.07
CTS Price Earnings VS Forward Price EarningsCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTS indicates a somewhat cheap valuation: CTS is cheaper than 70.83% of the companies listed in the same industry.
CTS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CTS is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.81
EV/EBITDA 15.08
CTS Per share dataCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of CTS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.28
EPS Next 2Y4.07%
EPS Next 3Y7.26%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.31%, CTS is not a good candidate for dividend investing.
CTS's Dividend Yield is rather good when compared to the industry average which is at 1.87. CTS pays more dividend than 82.50% of the companies in the same industry.
With a Dividend Yield of 0.31, CTS pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

CTS has paid a dividend for at least 10 years, which is a reliable track record.
CTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years31
CTS Yearly Dividends per shareCTS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

CTS pays out 8.23% of its income as dividend. This is a sustainable payout ratio.
DP8.23%
EPS Next 2Y4.07%
EPS Next 3Y7.26%
CTS Yearly Income VS Free CF VS DividendCTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M
CTS Dividend Payout.CTS Dividend Payout, showing the Payout Ratio.CTS Dividend Payout.PayoutRetained Earnings

CTS CORP

NYSE:CTS (1/21/2025, 8:04:00 PM)

After market: 52.84 0 (0%)

52.84

+1.2 (+2.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners100.16%
Inst Owner Change-0.02%
Ins Owners2.11%
Ins Owner Change-4.48%
Market Cap1.59B
Analysts45
Price Target49.98 (-5.41%)
Short Float %1.62%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.16
Dividend Growth(5Y)0%
DP8.23%
Div Incr Years0
Div Non Decr Years31
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.48%
Min EPS beat(2)1.45%
Max EPS beat(2)15.51%
EPS beat(4)4
Avg EPS beat(4)6.77%
Min EPS beat(4)1.38%
Max EPS beat(4)15.51%
EPS beat(8)6
Avg EPS beat(8)3.96%
EPS beat(12)9
Avg EPS beat(12)4.88%
EPS beat(16)13
Avg EPS beat(16)9.8%
Revenue beat(2)0
Avg Revenue beat(2)-2.2%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)-0.84%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)5
Avg Revenue beat(12)-0.16%
Revenue beat(16)9
Avg Revenue beat(16)1.03%
PT rev (1m)0%
PT rev (3m)13.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.89%
EPS NY rev (1m)0%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 25.04
Fwd PE 22.07
P/S 3.1
P/FCF 17.81
P/OCF 15.1
P/B 3
P/tB 10.26
EV/EBITDA 15.08
EPS(TTM)2.11
EY3.99%
EPS(NY)2.39
Fwd EY4.53%
FCF(TTM)2.97
FCFY5.61%
OCF(TTM)3.5
OCFY6.62%
SpS17.03
BVpS17.62
TBVpS5.15
PEG (NY)N/A
PEG (5Y)3.28
Profitability
Industry RankSector Rank
ROA 7.58%
ROE 11.27%
ROCE 11.1%
ROIC 8.57%
ROICexc 9.94%
ROICexgc 27.32%
OM 14.84%
PM (TTM) 11.66%
GM 36%
FCFM 17.42%
ROA(3y)3.28%
ROA(5y)4.2%
ROE(3y)4.74%
ROE(5y)6.27%
ROIC(3y)10.77%
ROIC(5y)9.58%
ROICexc(3y)14.41%
ROICexc(5y)12.45%
ROICexgc(3y)29.6%
ROICexgc(5y)24.47%
ROCE(3y)13.96%
ROCE(5y)12.41%
ROICexcg growth 3Y24.45%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y16.11%
ROICexc growth 5Y-2.34%
OM growth 3Y10.5%
OM growth 5Y1.24%
PM growth 3Y10.36%
PM growth 5Y2.16%
GM growth 3Y1.87%
GM growth 5Y-0.23%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.15
Debt/EBITDA 0.97
Cap/Depr 53.61%
Cap/Sales 3.13%
Interest Coverage 21.43
Cash Conversion 99.39%
Profit Quality 149.36%
Current Ratio 2.46
Quick Ratio 1.91
Altman-Z 6.03
F-Score5
WACC10.42%
ROIC/WACC0.82
Cap/Depr(3y)52.53%
Cap/Depr(5y)60.32%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.26%
EPS 3Y25.43%
EPS 5Y7.63%
EPS Q2Q%16.67%
EPS Next Y-0.37%
EPS Next 2Y4.07%
EPS Next 3Y7.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y9.08%
Revenue growth 5Y3.19%
Sales Q2Q%-1.58%
Revenue Next Year-5.29%
Revenue Next 2Y0.12%
Revenue Next 3Y2.05%
Revenue Next 5YN/A
EBIT growth 1Y-12.44%
EBIT growth 3Y20.53%
EBIT growth 5Y4.47%
EBIT Next Year21.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.9%
FCF growth 3Y6.17%
FCF growth 5Y20.06%
OCF growth 1Y-13.44%
OCF growth 3Y4.96%
OCF growth 5Y8.82%